URGN
UroGen Pharma Ltd.stockNASDAQ
At CloseOct 2, 2026 3:59:55 PM EDT
41.38USD+2.047%(+0.83)604,961
URGN News
Take the Zacks Approach to Beat the Markets: Oportun Financial, Uranium Royalty & Amgen in Focus ·
Zacks Investment Research
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) ·
GlobeNewswire Inc.
